儿科非传染性器官特异性免疫病理的负担 儿科常见可变免疫缺陷的负担
Aleksandra Szczawińska-Popłonyk1, Julia Bekalarska2, Kacper Jęch2
1Department of Pediatric Pneumonology, Allergy and Clinical Immunology, Institute of Pediatrics, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
儿科常见可变免疫缺陷 (CVID) 涉及免疫失调,导致器官特异性并发症. 了解它的遗传基础和免疫类型是针对性治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 儿科常见可变免疫缺陷 (CVID) 是一种主要免疫缺陷,其特征是抗体生产缺陷.
- 冠状病毒感染有传染性,自身免疫性,炎症性和淋巴增殖性并发症,影响多个器官系统.
- 免疫失调,特定的B细胞和T细胞子集异常以及遗传异质性有助于CVID复杂的病理.
研究的目的:
- 在儿科CVID中定义和划分器官特异性免疫病理学.
- 整合关于CVID复杂免疫表型,免疫失调机制和遗传基础的数据.
- 促进针对儿科CVID的个性化向疗法的开发.
主要方法:
- 关于儿科CVID的现有文献的审查.
- 免疫遗传发现的分析及其与临床表型的相关性.
- 检查免疫失调路径和生物标志物的检查.
主要成果:
- 冠状病毒感染与免疫失调和特定的免疫表型生物标志物有关,包括扩展的CD21低B细胞和改变的T细胞子集.
- 在TACI,CTLA-4,LRBA,NFKB1/2和PIK3CD/R1等基因中的遗传变异影响CVID病变.
- 在CVID中,器官特异性免疫病理包括粒状肺病,肠病,神经病,内分泌病和皮肤病.
结论:
- 了解遗传背景,免疫失调和免疫类型之间的相互作用对于管理儿科CVID至关重要.
- 特定器官的表现突出显示了CVID相关免疫病理的系统性质.
- 包括生物药物在内的个性化治疗策略,有望改善儿科CVID的结果.
更多相关视频
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
相关概念视频
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Humoral Immune Responses
Cell-mediated Immune Responses
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
